GIHOMO leans on patents, testing and ISO systems to sell hyperbaric chambers

GIHOMO is positioning its hyperbaric oxygen chamber business around compliance and intellectual property as it expands sales in Europe, the U.S. and other export markets. The company’s public materials show multiple CE, EMC and ISO certificates, but do not establish product-specific U.S. clearance or fully verified patent and trademark records.

Why it matters: - GIHOMO’s pitch to global buyers is built around documentation, not marketing language. - For medical and wellness equipment buyers, the difference between electrical test compliance and medical-device authorization can determine whether a chamber can be legally used, imported or sold in a target market. - The company says about 60% of output is exported, with the European Union and the United States as key markets.

What happened: - GUANGDONG GIHOMO MEDICAL TECHNOLOGY CO., LTD. is a hyperbaric oxygen chamber manufacturer based in Shunde district, Foshan, Guangdong province, China. - The company was founded in 2021 and makes hard shell, soft shell and portable hyperbaric oxygen chambers for clinical, wellness, sports and home-use channels. - GIHOMO says it has a research and development team of six engineers and invests annually in new materials, new processes and new product forms. - Public materials reviewed for this report do not list specific patent numbers, design registrations, software copyrights or overseas trademark records. - The company’s export footprint is described as spanning the European Union, North America, South America, Australia and New Zealand.

The details: - GIHOMO’s catalogue includes steel and aluminium hard shell chambers, TPU soft shell chambers, portable chamber units and multi-patient configurations. - Advertised pressure ranges span 1.3 ATA to 2.0 ATA. - On the soft shell side, listed models include the STW03 lying-type chamber at 1.5 ATA, the SSL001 at 1.5 ATA, the SS002 two-person portable chamber at 1.3 ATA, the SC001 sitting-type chamber at 1.3 ATA and the SH001 lying-type portable chamber at 2.0 ATA. - On the hard shell side, listed models include the Z0780V, Y1800 two-person chamber, W900 sitting-type unit, W1800, and aluminium C750 and C900 lying-type chambers rated up to 2.0 ATA. - Multi-patient and BIBS-equipped configurations include the P4200 eight-sitter at 1.3 ATA, the P1800M, R1800M and P5480M. - GIHOMO says customization is available for logo, interface, colour and language. - The company reports a minimum order quantity of one unit, a lead time of 30 to 45 days, monthly capacity of 80 units and a one-year warranty. - GIHOMO also reports annual output of 1,000 units, a 2,000-square-metre factory floor area and a workforce of 50 to 100 people. - Reference cases cited by the company include home use across 27 markets, beauty salon and spa installations, gym use, wellness centre deployments and an ODM reseller programme.

Between the lines: - The company is trying to separate itself from generic chamber sellers by tying its brand story to engineering, certificates and management systems. - That approach can matter in procurement, but only if buyers verify each claim in public registries and certificate databases. - The public materials reviewed do not establish a product-specific U.S. 510(k) clearance for GIHOMO chambers. - In Europe, the CE and EMC records on file support electrical safety and electromagnetic compatibility for covered configurations, but they are not the same as Medical Device Regulation authorization. - The company’s environmental claims stop at ISO 14001 certification; no third-party verified carbon footprint, life-cycle assessment or net-zero date is disclosed.

What's next: - Buyers evaluating GIHOMO should confirm any patent, design or trademark claims against the relevant official registries before procurement. - U.S. buyers should verify FDA clearance status directly in the public database before making medical-use claims. - Purchasers should also check the exact model, scope and annexes attached to each CE, EMC and ISO certificate before relying on them for compliance planning. - The company’s next credibility step would be publishing verifiable patent, trademark and product-clearance records.

The bottom line: - GIHOMO has assembled a documentation-heavy sales case, but the strongest claims still need registry-level verification before buyers can treat them as fully auditable.